Description

BSE announces trading in Rights Entitlements (REs) for Vineet Laboratories Limited from January 1, 2026 to January 16, 2026, with the rights issue opening January 1-21, 2026.

Summary

BSE has announced that trading in Rights Entitlements (REs) for renunciation of Vineet Laboratories Limited will commence from January 1, 2026. The REs will be tradable in dematerialized form only on a T+1 rolling settlement basis with trade-for-trade settlement. The rights issue opens on January 1, 2026 and closes on January 21, 2026.

Key Points

  • Rights Entitlements trading period: January 1, 2026 to January 16, 2026
  • Rights Issue period: January 1, 2026 to January 21, 2026
  • Scrip Code: 751072
  • Scrip ID: VINEET-RE
  • ISIN: INE505Y20010
  • Market Lot: 1
  • Group: R
  • Settlement: T+1 Rolling Settlement on trade-for-trade basis
  • Trading form: Dematerialized only
  • REs that are neither subscribed nor renounced will lapse and be extinguished after issue closing date

Regulatory Changes

No regulatory changes. This is a standard rights entitlement trading notification in accordance with existing BSE procedures outlined in notice 20200305-21 (March 5, 2020) and notice 20200518-34 (May 18, 2020).

Compliance Requirements

  • Trading Members must inform all clients about commencement of RE trading, mentioning the ISIN (INE505Y20010)
  • Trading Members must clarify that REs are not ordinary shares of the company
  • Contract notes/bills for RE purchases must include a prominent disclaimer explaining that:
    • Purchase of REs only gives the right to participate in the ongoing rights issue by making application with requisite money OR renounce the REs before issue closes
    • REs neither subscribed nor renounced before issue closing date will lapse and be extinguished
  • Trading Members should refer to notice 20200305-21 (March 5, 2020) and notice 20200518-34 (May 18, 2020) for additional details

Important Dates

  • January 1, 2026: Rights Entitlements trading commences; Rights Issue opens
  • January 16, 2026: Last day for RE trading/renunciation
  • January 21, 2026: Rights Issue closes; deadline for subscription or renunciation to avoid lapse

Impact Assessment

This circular has medium impact limited to shareholders and potential investors of Vineet Laboratories Limited. Existing shareholders who receive rights entitlements can either subscribe to the rights issue, sell their entitlements during the trading window (January 1-16, 2026), or allow them to lapse. The T+1 settlement and trade-for-trade basis ensures transparent tracking of RE transactions. Market impact is confined to this specific company’s shareholders and does not affect broader market operations.

Impact Justification

Standard rights entitlement trading notification affecting shareholders of Vineet Laboratories Limited with specific trading window and settlement requirements